DCGI tells aesthetic clinics, beauty brands: cosmetics are for beautifying, not treatment
India's drug regulator issued a public notice warning cosmetics manufacturers, importers and aesthetic clinics against marketing products as injectables or therapeutic treatments. Notice flags misleading claims, prohibited ingredients and label tampering under the Drugs and Cosmetics Act — putting premium beauty and derma-cosmetic brands on notice.
DCGI issued a public notice clarifying cosmetics cannot be used as injectables or for treatment, warning manufacturers, importers, and aesthetic clinics against misleading claims, prohibited ingredients, and label tampering under the Drugs and Cosmetics Act.
Why this matters
Second CDSCO move in weeks against the aesthetic category, following its bar on cosmetic injectables that squeezed clinic chains. Signals a widening crackdown on derma-cosmetic claims and label compliance.
Retail-brand signals steady at 446 over the last 90 days.